Delivery Order SPE2DB20D1110-SPE2DB23FK16A
- Not listed
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, under the DLA's Indefinite Delivery Contract (IDC) SPE2DX worth up to $999,999,999.00. The delivery order, valued at $40,408.99, is for the supply of Concerta ER (methylphenidate hydrochloride) 36 mg tablets, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract is a firm-fixed-price, non-set-aside delivery order with a...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 36mg Concerta ER Tablets, a prescription medication used to treat attention deficit hyperactivity disorder (ADHD). The contract has a ceiling value of $10,059.75 and a performance period ending on May 8, 2025. The contract is a firm fixed-price delivery order and is not set aside...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Concerta ER 36 mg tablets, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has a ceiling value of $10,795.92 and a performance period ending on May 5, 2025. It is a firm-fixed-price contract, meaning the price will not change regardless of the contractor's costs. The...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Concerta ER Tablets 36mg, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract is a firm-fixed-price delivery order with a ceiling value of $19,996.77 and a period of performance ending on July 1, 2025. The contract is not set aside for any...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $24,401.28 firm-fixed-price contract is for the delivery of Concerta ER 36 mg tablets, a prescription medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,965.46 firm fixed-price contract is for the delivery of Concerta ER 54 mg tablets, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has an ultimate completion date of April 19, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $3,552.18 fixed-price contract is for the supply of Concerta ER 36 mg tablets, a specialty medication used for the treatment of attention-deficit/hyperactivity disorder (ADHD). The contract has an ultimate completion date of July 25, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Concerta ER 54 mg tablets, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has a ceiling value of $1,010.88 and a period of performance through July 7, 2025. This award is not designated as a set-aside contract, indicating open...
- This federal contract award, valued at $15,770.41, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 100 units of Concerta ER 36 mg tablets, a medication used to treat Attention Deficit Hyperactivity Disorder (ADHD). This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent...
- This contract award to Amerisourcebergen Drug Corp, a pharmaceutical distribution company, is a Delivery Order valued at $12,931.39 under a Defense Logistics Agency (DLA) Indefinite Delivery Contract (IDC). The order is for the supply of Concerta ER 27 mg tablets, a medication used for the treatment of attention-deficit/hyperactivity disorder (ADHD). The contract has an ultimate completion date of July 27, 2023 and was awarded on a Firm Fixed Price basis without any set-aside designation,...
- SPE2DB20D1110Indefinite Delivery Contract
- SPE2DB20D1110-SPE2DB23FK16ADelivery Order
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00. The contract covers the delivery of Concerta ER 36 mg tablets, a prescription medication used to treat attention deficit hyperactivity disorder (ADHD). The delivery order has a ceiling value of $7,108.57 and a completion date of May 3, 2023. The contract is a firm-fixed-price type and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which is also a prime contractor for the DLA and the Department of Justice Federal Bureau of Investigation for similar medical product and prescription drug procurement contracts. These IDCs enable the government to efficiently acquire essential pharmaceutical and medical supplies to support military, veteran, and other federal healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.1k | 5/2/23 |